The total return over the past 12 months is -44.34% vs. +16.94% for the S&P 500. So far it's up +7.08% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (44.34%) | (43.07%) | (56.07%) | N/A | N/A | N/A |
| Total Return CAGR | (44.34%) | (43.07%) | (56.07%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
ALX Oncology Holdings Inc. (ALXO)
| Year | Start price | End price | ALXO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.13 | $1.21 | +7.08% | +14.51% | (7.43%) |
| 2025 | $1.67 | $1.13 | (32.34%) | +17.72% | (50.06%) |
| 2024 | $14.89 | $1.67 | (88.78%) | +24.89% | (113.67%) |
| 2023 | $11.27 | $14.89 | +32.12% | +26.19% | +5.93% |
| 2022 | $21.49 | $11.27 | (47.56%) | (18.17%) | (29.39%) |
| 2021 | $86.20 | $21.49 | (75.07%) | +28.74% | (103.81%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
